Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.57 +0.15 (+10.21%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Preferred Stock Liabilities (2020 - 2021)

Updated

Nautilus Biotechnology's Preferred Stock Liabilities came in at $138.47 million for Q1 2021, down 1.3% from the prior quarter.

Analysis

Nautilus Biotechnology (NAUT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Nautilus Biotechnology's Preferred Stock Liabilities was $140.24 million.

  • The five-year range for quarterly Preferred Stock Liabilities is $108.42 million (Q2 2020) to $140.59 million (Q3 2020).
  • Business Quant data shows NAUT's Preferred Stock Liabilities at $140.24 million (Q4 2020), $140.59 million (Q3 2020) and $108.42 million (Q2 2020) in the three quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Nautilus Biotechnology 180.66 Mn 180.66 Mn 175,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 138.47 Mn
Dec 31, 2020 140.24 Mn
Sep 30, 2020 140.59 Mn
Jun 30, 2020 108.42 Mn
API Access

Nautilus Biotechnology Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NAUT&period=max&api_key=YOUR_API_KEY